Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fabrication of a quaternary ammonium chitosan/pomelo peel extract nanocarrier system for tea polyphenol delivery: characterization, stability, digestibility, and release properties.

Food chemistry: X·2026
Same author

The Biology of Malaria Parasite Liver Infection.

Cold Spring Harbor perspectives in medicine·2026
Same author

Effects of a Digital Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Symptoms: A Three-Arm Waitlist Randomized Controlled Trial.

European journal of investigation in health, psychology and education·2026
Same author

Development and psychometric analysis of 5-item Artificial Intelligence Attitude (AIAT-5) for students.

BMC psychology·2026
Same author

Qitu qushi formula ameliorates diabetic kidney disease potentially through gut microbiota-derived indole-3-propionic Acid-Mediated regulation of the Sirt1/FoxO1 pathway.

Frontiers in pharmacology·2026
Same author

Amino acid functionalization-induced dipole regulation suppresses carrier decay in perylene diimide to enhance photocatalytic activity.

Journal of hazardous materials·2026

Related Experiment Video

Updated: Jun 17, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Advances and challenges in malaria vaccine development.

Ruobing Wang1, Joseph D Smith, Stefan H I Kappe

  • 1Seattle Biomedical Research Institute and Department of Global Health, University of Washington, Seattle, Washington, USA.

Expert Reviews in Molecular Medicine
|December 17, 2009
PubMed
Summary
This summary is machine-generated.

Developing effective malaria vaccines is crucial for combating this devastating disease. While challenges exist, progress in subunit and live-attenuated vaccines offers hope for controlling Plasmodium parasite infections.

More Related Videos

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

Related Experiment Videos

Last Updated: Jun 17, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Vaccinology

Background:

  • Malaria, caused by Plasmodium parasites transmitted by Anopheles mosquitoes, is a major global health threat.
  • The complex Plasmodium life cycle involves mosquito and human hosts, complicating vaccine development.
  • Plasmodium's ability to evade immune responses presents a significant hurdle for vaccine efficacy.

Purpose of the Study:

  • To review the challenges and progress in malaria vaccine research and development.
  • To highlight the potential of different vaccine approaches, including subunit and live-attenuated vaccines.
  • To discuss the role of vaccines in malaria elimination strategies.

Main Methods:

  • Review of current malaria vaccine research and development efforts.
  • Analysis of obstacles in targeting specific Plasmodium species and life cycle stages.
  • Evaluation of subunit and live-attenuated vaccine candidate progress.

Main Results:

  • Significant obstacles exist due to Plasmodium's complexity and immune evasion tactics.
  • Progress is evident in partially efficacious recombinant pre-erythrocytic and live-attenuated sporozoite vaccines.
  • Subunit vaccine approaches have been a major focus, alongside live-attenuated parasite strategies.

Conclusions:

  • Partially effective malaria vaccines may complement existing control measures.
  • Highly effective vaccines are likely essential for the ultimate elimination of malaria.
  • Continued research into diverse vaccine strategies is critical for malaria eradication.